Literature DB >> 8652397

Characterization of an acquired IgG inhibitor of coagulation factor XIII in a patient with systemic lupus erythematosus.

F Ahmad1, S Solymoss, M C Poon, C Berube, A K Sullivan.   

Abstract

An acquired IgG inhibitor to factor XIII was identified in a 30-year-old Vietnamese woman with systemic lupus erythematosus. The IgG fraction was isolated from plasma by chromatography on an agarose gel column and by protein G adsorption. The anti-factor XIII activity, identified within the IgG fraction, inhibited factor XIII from both normal plasma (a2b2) and platelets (a2). A normal level of the b subunit was measured by immunoelectrophoresis of the patient's plasma, but the a subunit was not detected. These results suggested the presence of an IgG immunoglobulin which recognized the a subunit and interfered with its activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8652397     DOI: 10.1046/j.1365-2141.1996.d01-1678.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  [Thrombelastometric detection of factor XIII deficiency].

Authors:  C F Weber; C Jambor; M Marquardt; K Görlinger; B Zwissler
Journal:  Anaesthesist       Date:  2008-05       Impact factor: 1.041

Review 2.  Acquired FXIII inhibitors: a systematic review.

Authors:  Massimo Franchini; Francesco Frattini; Silvia Crestani; Carlo Bonfanti
Journal:  J Thromb Thrombolysis       Date:  2013-07       Impact factor: 2.300

3.  New developments in the management of congenital Factor XIII deficiency.

Authors:  Zehra Fadoo; Quratulain Merchant; Karim Abdur Rehman
Journal:  J Blood Med       Date:  2013-05-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.